We are developing novel technologies for pain management and rehabilitation

Health Canada licensed laboratory in Toronto approved for the research and development of scheduled drugs.

Grant Funded Studies including research at Queen’s University investigating for chronic pain, depression, musculoskeletal disorders and the alteration of sensory perception.

Leveraging 50+ Years in organic synthesis to discover and develop valuable drug candidates.

Peer Reviewed Publications covering various medical segments including spinal cord stimulation, nervous system diseases and injuries, addiction, psychedelics and psychiatric medicines.

Management Team has significant clinical, pharmaceutical and chemical manufacturing experience, including Novo Nordisk, Orthofix and Spaulding Clinical Research.

Seeking help and unsure where to start?

Get in touch.